WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
WX was delisted on the 10th of December, 2015.
154 hedge funds and large institutions have $2.48B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2015 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 38 increasing their positions, 59 reducing their positions, and 33 closing their positions.
43% more funds holding in top 10
Funds holding in top 10: 7 → 10 (+3)
21% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 33
5% more funds holding
Funds holding: 147 → 154 (+7)
4% more capital invested
Capital invested by funds: $2.39B → $2.48B (+$87.2M)
36% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 59
74% less call options, than puts
Call options by funds: $3.46M | Put options by funds: $13.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
+$49.6M |
| 2 |
O
OppenheimerFunds
New York
|
+$41.9M |
| 3 |
SC
Sculptor Capital
New York
|
+$37.3M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$32.9M |
| 5 |
NA
Newport Asia
San Francisco,
California
|
+$30.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$74.9M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
-$51.5M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
-$39.6M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$38.3M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$27.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WC
176
Wexford Capital
West Palm Beach,
Florida
| – | -$316K | -8,151 | Closed |
|
|
IRS
177
Invictus RG (Singapore)
Singapore
| – | -$283K | -7,300 | Closed |
|
|
OC
178
Oppenheimer & Co
New York
| – | -$255K | -6,579 | Closed |
|
|
CSS
179
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$233K | -6,012 | Closed |
|
|
B
180
BancorpSouth
Tupelo,
Mississippi
| – | -$220K | -5,681 | Closed |
|
|
HNB
181
Huntington National Bank
Columbus,
Ohio
| – | -$182K | -4,694 | Closed |
|
|
BC
182
Bartlett & Co
Cincinnati,
Ohio
| – | -$71K | -1,825 | Closed |
|
183
Creative Planning
Overland Park,
Kansas
| – | -$48K | -1,250 | Closed |
|
|
ACS
184
Archford Capital Strategies
Swansea,
Illinois
| – | -$29.3K | -755 | Closed |
|
|
FMII
185
Farmers & Merchants Investments Inc
Lincoln,
Nebraska
| – | -$9K | -224 | Closed |
|
|
TRCT
186
Tower Research Capital (TRC)
New York
| – | -$7.84K | -186 | Closed |
|
|
CAM
187
ClariVest Asset Management
San Diego,
California
| – | -$6K | -161 | Closed |
|
|
ZB
188
Zions Bancorporation
Salt Lake City,
Utah
| – | -$5K | -133 | Closed |
|
WX Hedge Fund Activity: Q2 2015 in Review
154 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q2 2015, worth a combined $2.48B — up 3.6% from $2.39B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new WX positions and 33 closed out — a net gain of 7 holders — while 38 added to existing stakes and 59 trimmed.
The largest buyer was Hillhouse Investment Management, opening a new position worth an estimated $49.6M. The largest seller was Fidelity Investments, cutting an estimated $74.9M.
- 154 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q2 2015, up from 147 in Q1 2015.
- Funds reported $2.48B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q2 2015, up 3.6% quarter-over-quarter.
- 40 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q2 2015 and 33 closed out, a net change of +7 holders.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q2 2015 was Hillhouse Investment Management, an estimated $49.6M added.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q2 2015 was Fidelity Investments, an estimated $74.9M sold.
Based on aggregated 13F filings for Q2 2015.